期刊文献+

人CD46启动子真核表达载体的构建 被引量:4

Construction of Eukaryotic Expression Vectors by Use of Human CD46 Promoter
下载PDF
导出
摘要 为了构建人CD46(hCD46)启动子指导目的基因表达的真核表达载体,提取HeLa细胞基因组DNA,用PCR扩增出hCD46基因的启动子区域,序列分析结果表明其与GenBank中hCD46基因5′端某片段的同源性为99.9%。用此启动子替换pcDNA3EGFP中的CMV启动子,并在hCD46启动子和EGFP基因之间插入兔β-球蛋白基因第二内含子(RGI),得到的重组表达载体转染CHO和SP2/0两种鼠源细胞,流式细胞术检测表明CHO细胞EGFP的表达量高于SP2/0细胞,表达特性与人体CD46相似;RGI可以增强EGFP的表达量,但不改变其表达的组织特异性,提示克隆的hCD46启动子可以用于研制模拟人体CD46基因表达特性的转基因小鼠。 To construct eukaryotic expression vectors that utilize human CD46 promoter to drive expression of genes, hCIM6 promoter was amplified by PCR using genomic DNA from HeLa cells as template. The PCR product of 1.5 kb was subcloned into pMD18-T vector and submitted to sequence analysis. Nucleotide sequence alignment showed that the self-cloned hCD46 promoter was 99.9% homologous with a DNA fragment from the 5' end of hCD46 gene published in 2006, differing only in 2 nucleotides. The hCD46 promoter was used to replace the CMV early promoter in pcDNA3EGFP; and the rabbit β-globulin gene intron 2 (RGI) was inserted between hCD46 promoter and EGFP gene in order to enhance the expression level of the gene of interest. The recombinant expression vectors,pCDPEGFP and pCDPEGFP-RGI, were transfected into CHO and SP2/0 cells, respectively. Detection by FACS revealed that the expression level of EGFP in transfected CHO cells was higher than that in transfected SP2/0 cells, similarly to the expression property of hCD46 in vivo in human. RGI could enhance the expression level of EGFP in each cell line without altering the cell line-specific expression characterization. These data indicate that the eukaryotic expression vectors containing human CD46 promoter could be suitable for the development of transgenic mice that mimic the expression properties of hCD46.
机构地区 扬州大学医学院
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第11期11-15,共5页 China Biotechnology
基金 江苏省自然科学基金资助项目(BK2005406) 江苏省高校自然科学基金资助项目(07KJD310244)
关键词 hCD46启动子 真核表达载体 EGFP hCD46 promoter Eukaryotic expression vector EGFP
  • 相关文献

参考文献15

  • 1Riley-Vargas R C, Gill D B, Kemper C, et al. CD46 : expanding beyond complement Regulation. Trends Immunol,2004,25 (9) : 496 - 503.
  • 2Liszewski M K, Post T W, Atkinson J P. Membrane cofactor protein ( MCP or CD46) : newest member of the regulators of complement activation gene cluster. Ann Rev Immunol, 1991,9: 431 - 455.
  • 3Gordon D L, Sadlon T A, Wesselingh S L, et al. Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation. J Neuro Immunol, 1992,36 (2 -3) : 199 -208.
  • 4Seya T, Hara T, Matsumoto M, et al. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down -regulated during cell differentiation. J Immunol, 1990, 145 (1) : 238 -245.
  • 5Cho S W, Oglesby T J, Hsi B L, et al. Characterization of three monoclonal antibodies to membrane co-factor protein (MCP)of the complement system and quantification of MCP by radioassay. Clin Exp Immunol,1991,83(2) : 257 -261.
  • 6Cui W Y, Hourcade D, Post T, et al. Characterization of the promoter region of the membrane cofactor protein ( CD46 ) gene of the human complement system and comparison to a membrane cofactor protein -like genetic element. J Immunol, 1993, 151 (8) : 4137 -4146.
  • 7Naniche D, Varior- Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol, 1993,67 (10) : 6025 - 6032.
  • 8Okada N, Liszewski M K, Atkinson J P, et al. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A,1995,92 (7) : 2489 -2493.
  • 9Santoro F, Kennedy P E, Locatelli G, et al. CD46 is a cellular receptor for human herpesvims 6. Cell, 1999,99 ( 7 ) : 817 - 827.
  • 10KaUstrom H, Liszewski M K, Atkinson J P, et al. Membrane cofactor protein ( MCP or CD46 is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol, 1997,25 (4) : 639 - 647.

同被引文献65

  • 1郑斌,詹希美.信号肽序列及其在蛋白质表达中的应用[J].生物技术通讯,2005,16(3):296-298. 被引量:45
  • 2姜永萍,张洪波,步志高,李呈军,赵有淑,王秀荣,于康震,陈化兰.表达载体pCAGGS显著增强禽流感DNA疫苗的免疫保护效果[J].中国农业科学,2006,39(4):825-830. 被引量:29
  • 3郝春丽,田兆龙,陈同,王泽霖.禽用基因疫苗的研究进展[J].上海畜牧兽医通讯,2007(2):11-13. 被引量:2
  • 4Koomey M. Implications of molecular contacts and signaling initiated by Neisseria gonorrhoeae. Curr Opin Microbiol, 2001, 4( 1 ) : 53-57.
  • 5Dehio C, Gray-Owen SD, Meyer TF. The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol, 1998, 6 (12) : 489-495.
  • 6Christof RH, Thomas FM. "Small" talk : Opa proteins as mediators of Neisseria-host-cell communication. Curr Opin Microbiol, 2003, 6(1) : 43-49.
  • 7Beauchemin N, Draber P, Dveksler G. Redefined nomenclature for members of the earcinoembryonie antigen family. Exp Cell Res, 1999, 252(2) : 243-249.
  • 8Chen T, Grunert F, Medina-Marino A, et al. Several carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity proteins. J Exp Med, 1997, 185(9) : 1557-1564.
  • 9Gray-Owen SD, Dehio C, Haude A, et al. CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J,1997, 16(12) : 3435-3445.
  • 10Singer BB, Scheffrahn I, Heymann R, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphasphatidylinasitol-linked proteins in human leukocytes. J Immunol, 2002, 168 (10) : 5139-5146.

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部